One Year of Preservé Breast Augmentation: Dr. Mark Epstein Reports Zero Capsular Contracture Across Full Case Series
Mark D. Epstein, MD, FACS, is a board-certified plastic surgeon whose experience with Motiva® breast implants began in 2018 as a Principal Investigator in the U.S. FDA clinical trial. He has since performed 161 Preservé breast augmentation procedures and
Dr. Mark D. Epstein performs a Preservé breast augmentation procedure utilizing tissue-preserving surgical principles developed through years of clinical experience with Motiva® breast implants.
Dr. Mark D. Epstein demonstrates the Preservé breast augmentation technique during a surgeon education program. To date, he has trained 57 plastic surgeons through educational programs, workshops, and surgical training sessions.
The Motiva® Preservé™ Disposable Toolkit, developed to support the Preservé breast augmentation technique and its tissue-preserving surgical approach.
The Epstein Breast Preservation Channel Dilator, a specialized surgical instrument designed by Dr. Mark D. Epstein to facilitate atraumatic channel creation during the Preservé® breast augmentation procedure.
First anniversary of the Preservé breast augmentation technique with a complete 12 month outcomes review across a consecutive series of 210 procedures.
Since performing the first Preservé procedure at his Hauppauge practice on September 10, 2025, Dr. Epstein has tracked every case without exception. Across 420 breasts, the twelve-month data show zero cases of Grade III/IV capsular contracture, zero infections, zero implant ruptures, and zero cases of lost nipple sensation. Two reoperations for complications were recorded in the full series, a rate of 0.4 percent.
Dr. Epstein is one of only twelve surgeons nationally trained to teach the Preservé technique to other plastic surgeons, and served as a paid investigator in the Motiva U.S. FDA clinical trial that led to the implant's approval in September 2024. He has personally trained 67 surgeons in the technique to date.
"I have been doing this for over thirty years, and I have never had a technique change my outcomes this fast. The data after one year makes the case better than I can," said Dr. Epstein.
Dr. Epstein was also named to Newsweek's list of America's Best Plastic Surgeons 2026, recognized in five categories: breast augmentation, rhinoplasty, eye lift, liposuction, and tummy tuck.
The Preservé technique is offered alongside a range of anesthesia options at Epstein Plastic Surgery, including a wide awake approach for appropriate candidates. Fifteen of the 210 procedures in the one year series were performed wide awake.
Dr. Epstein is a paid investigator in the Motiva U.S. FDA clinical trial and is compensated by Establishment Labs to train surgeons on the Preservé technique. Dr. Epstein owns stock in Establishment Labs.
Full case mix and outcomes data are available at epsteinplasticsurgery.com/is-preserve-breast-augmentation-worth-it/.
About Epstein Plastic Surgery
Epstein Plastic Surgery is a Hauppauge, NY practice specializing exclusively in cosmetic surgery, with an on site accredited surgical facility and an on site medspa, Oceane Medical Aesthetics and Wellness. Both facilities are accredited by QUAD A. Dr. Mark Epstein has practiced plastic surgery on Long Island for more than 30 years.
Mark D Epstein MD PC
Mark D Epstein MD PC
+1 631-689-1100
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
